Between persuasion and compulsion: The case of COVID-19 vaccination in Canada

Eve Dubé; Dominique Gagnon; Noni MacDonald

doi:10.1016/j.vaccine.2022.05.053

Between persuasion and compulsion: The case of COVID-19 vaccination in Canada

Eve Dubé, Dominique Gagnon, Noni MacDonald

Computer Science

科研成果: 期刊稿件 › 评论/辩论 › 同行评审

5 引用（Scopus）

源语言	英语
页（从-至）	3923-3926
页数	4
期刊	Vaccine
卷	40
期	29
DOI	https://doi.org/10.1016/j.vaccine.2022.05.053
出版状态	已出版 - 6月 23 2022

!!!ASJC Scopus Subject Areas

分子药学
一般免疫学和微生物学
一般兽医学
公共卫生、环境和职业健康
传染病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.vaccine.2022.05.053

其它文件与链接

引用此

@article{84c11c5c6c5740a6a109a0f0f1d62c6f,

title = "Between persuasion and compulsion: The case of COVID-19 vaccination in Canada",

author = "Eve Dub{\'e} and Dominique Gagnon and Noni MacDonald",

note = "Funding Information: This commentary was supported by the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax). Thank you to the many authors, immunization partners, and reviewers who contribute to CANVax. Funding Information: CANVax is supported by the Immunization Partnership Funds of the Public Health Agency of Canada.",

year = "2022",

month = jun,

day = "23",

doi = "10.1016/j.vaccine.2022.05.053",

language = "English",

volume = "40",

pages = "3923--3926",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "29",

}

TY - JOUR

T1 - Between persuasion and compulsion

T2 - The case of COVID-19 vaccination in Canada

AU - Dubé, Eve

AU - Gagnon, Dominique

AU - MacDonald, Noni

N1 - Funding Information: This commentary was supported by the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax). Thank you to the many authors, immunization partners, and reviewers who contribute to CANVax. Funding Information: CANVax is supported by the Immunization Partnership Funds of the Public Health Agency of Canada.

PY - 2022/6/23

Y1 - 2022/6/23

UR - http://www.scopus.com/inward/record.url?scp=85131377753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131377753&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2022.05.053

DO - 10.1016/j.vaccine.2022.05.053

M3 - Comment/debate

C2 - 35637068

AN - SCOPUS:85131377753

SN - 0264-410X

VL - 40

SP - 3923

EP - 3926

JO - Vaccine

JF - Vaccine

IS - 29

ER -